Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2015

Mar 13, 2015

30870_dirs_2015-03-13_32ad4141-014e-49a0-b26b-74c8b6c65287.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2015-03-11

Reporting Person: WOLFF ANDREW A (SVP & CMO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-11 Common Stock M 2485 $6.3 Acquired 23746 Direct
2015-03-11 Common Stock S 100 $7.83 Disposed 23646 Direct
2015-03-11 Common Stock M 19390 $6.3 Acquired 43036 Direct
2015-03-11 Common Stock S 19390 $7.8 Disposed 23646 Direct
2015-03-11 Common Stock S 1040 $7.81 Disposed 22606 Direct
2015-03-11 Common Stock S 1345 $7.8 Disposed 21261 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-11 Incentive Stock Option (right to buy) $6.3 M 2485 Disposed 2022-03-05 Common Stock (2485) Direct
2015-03-11 Non-Qualified Stock Option (right to buy) $6.3 M 19390 Disposed 2022-03-05 Common Stock (19390) Direct